Stem Cell Inc.
company.status.inactiveCIK 1828613fmd_1HC0501E120PG0PF0M4GYYKNNYFinance, Insurance and Real Estate · Mineral Royalty TradersTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 15 periods
Latest annual · FY2022
Millions- Total revenues
- 0
- Net income
- (0)
- Free cash flow
- (0)
Latest quarter · Q3 FY2023
Millions- Total revenues
- 0
- Net income
- (0)
Stem Cell Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2023-04-14 · proof | |
| Net income | -$92,304 | -$54,333 | 10-K 2023-04-14 · proof | |
| Cash from operating activities | -$24,304 | -$47,231 | 10-K 2023-04-14 · proof | |
| Total assets | $7,697 | $12,001 | -35.9% | 10-K 2023-04-14 · proof |
| Total liabilities | $28,000 | $7,500 | +273.3% | 10-K 2023-04-14 · proof |
| Cash and cash equivalents | $7,299 | $11,603 | -37.1% | 10-K 2023-04-14 · proof |
- What was Stem Cell Inc.'s revenue in fiscal 2022?
- Stem Cell Inc. reported revenue of $0 for fiscal 2022 (the year ended Dec 31, 2022), against $0 the year before. Source: the 10-K filed with the SEC on Apr 14, 2023. SEC
- What was Stem Cell Inc.'s net income in fiscal 2022?
- Stem Cell Inc. reported net income of -$92,304 for fiscal 2022 (the year ended Dec 31, 2022), against -$54,333 the year before. Source: the 10-K filed with the SEC on Apr 14, 2023. SEC
- What was Stem Cell Inc.'s cash from operating activities in fiscal 2022?
- Stem Cell Inc. reported cash from operating activities of -$24,304 for fiscal 2022 (the year ended Dec 31, 2022), against -$47,231 the year before. Source: the 10-K filed with the SEC on Apr 14, 2023. SEC
- What are Stem Cell Inc.'s total assets?
- As of Dec 31, 2022, Stem Cell Inc. reported total assets of $7,697, against $12,001 a year earlier (-35.9%). Source: the 10-K filed with the SEC on Apr 14, 2023. SEC
- What are Stem Cell Inc.'s total liabilities?
- As of Dec 31, 2022, Stem Cell Inc. reported total liabilities of $28,000, against $7,500 a year earlier (+273.3%). Source: the 10-K filed with the SEC on Apr 14, 2023. SEC
- What are Stem Cell Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Stem Cell Inc. reported cash and cash equivalents of $7,299, against $11,603 a year earlier (-37.1%). Source: the 10-K filed with the SEC on Apr 14, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1828613&period_type=annual&limit=5"Information only, not investment advice.